Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 350 of 1,261
  1. US 10982001

    Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  2. US 10981977

    Anti-HERV-K envelope protein antibodies and methods for detecting HERV-K envelope protein in patients with sporadic amyotrophic lateral sclerosis

    THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  3. US 10981970

    Chimeric antigen receptor (CAR) comprising a CD22-binding domain

    AUTOLUS LIMITED · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  4. US 10981986

    Fusions of antibodies to CD38 and attenuated interferon alpha

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  5. US 10981944

    Modulators of 5′-nucleotidase, ecto and the use thereof

    Arcus Biosciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  6. US 10982068

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  7. US 10982012

    Dissolution of oxidized cellulose

    Covidien LP · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  8. US 10981943

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  9. US 10981902

    5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor

    Merck MSD (R&D) China Co., LTD. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  10. US 10981934

    Fused heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  11. US 10981894

    Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  12. US 10981860

    Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof

    Medshine Discovery Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  13. US 10981866

    Chemical conjugates of Evans Blue derivatives and their use as radiotherapy and imaging agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  14. US 10980990

    Systems, devices, and/or methods for managing transdermal patches

    N Brereton Medical Technologies, LLC · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  15. US 10980985

    Hydrodynamic method and apparatus for delivering fluids to kidney tissues

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  16. US 10980886

    Compositions of a polyorthoester and an organic acid excipient

    Heron Therapeutics, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  17. US 10980895

    Ionizable cationic lipid for RNA delivery

    ARCTURUS THERAPEUTICS, INC. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  18. US 10980885

    Method of reducing formation of etanercept aggregates or fragments

    Coherus BioSciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  19. US 10980884

    Stable aqueous etanercept composition

    Coherus BioSciences, Inc. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  20. US 10980872

    Genetically stable live attenuated respiratory syncytial virus vaccine and its production

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  21. US 10980868

    VEGFR-2 targeting immunotherapy approach

    Vaximm AG · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  22. US 10980848

    Antimicrobial therapy

    The Regents of the University of California · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  23. US 10980847

    Compositions and methods for detecting and treating brain injury associated fatigue and altered cognition (BIAFAC)

    The Board of Regents of the University of Texas System · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  24. US 10980846

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.